The US House of Representatives. A bill to accelerate the discovery, development, and delivery of 21st century cures, and for other purposes: 21st Century Cures Act n.d. H.R. 6, 114th Congress 2015–2016.
2.
AvornJ, KesselheimAS. The 21st Century Cures Act—Will it take us back in time?. N Engl J Med, 2015; 372:2473–2475.
3.
CallawayE. Young scientists lead the way on fresh ideas. Nature, 2015; 518:283–284.
4.
PageSE. The Difference: How the Power of Diversity Creates Better Groups, Firms, Schools, and Societies. Princeton University Press, Princeton, New Jersey. 2008.
5.
CondrenME, BradshawMD. Ivacaftor: A novel gene-based therapeutic approach for cystic fibrosis. J Pediatr Pharmacol Ther, 2013; 18:8–13.
6.
WartolowskaK, JudgeA, HopewellS, CollinsGS, DeanBJF, RombachI, BrindleyD, SavulescuJ, BeardDJ, CarrAJ. Use of placebo controls in the evaluation of surgery: Systematic review. BMJ, 2014; 348:g3253–g3253.
7.
BrindleyDA, RekhiR, Fuerstenau-SharpM, KantoffP, HollanderG, SmithJA, TindalS, TimminsN, BureK. The potential application of real-time release testing for the biomanufacture of autologous cell-based immunotherapies. BioProcess Int, 2015; 13:34–43.
8.
BubelaT, FitzGeraldGA, GoldER. Recalibrating intellectual property rights to enhance translational research collaborations. Sci Transl Med, 2012; 4:122cm3.
9.
RobertsM, WallIB, BinghamI, IcelyD, ReeveB, BureK, FrenchA, BrindleyD. The global intellectual property landscape of induced pluripotent stem cell technologies. Nat Biotechnol, 2014; 32:742–748.
